(NaturalNews) The current Pfizer attempt to gain FDA approval for marketing appears to be ignoring its own scientists' concerns. That's become business-as-usual with Big Pharma and the FDA.
A classic example is the neurotoxin aspartame, which FDA scientists refused authorize as safe for over a decade. Donald Rumsfeld had been strategically installed as CEO for G.D. Searle, aspartame's producer. From his temporary position of power in Ronald Reagan's transition team, Rumsfeld installed FDA governing officials who would overcome the scientists' objections.
This is merely one outrageous older example of Big Pharma manipulating the FDA. The corruption is worse now, prompting one blogger to post FDA as
Funded Depopulation Agenda rather than Food and Drug Administration.
Earlier, Reuters reported that FDA scientists were questioning the safety of Pfizer's latest toxic contribution to the world of medicine, a rheumatoid arthritis (RA) drug known as tofacitinib.
Days later, the same reporter explained that a U.S advisory panel
outside the FDA recommended approval of tofacitinib by a vote of 8 to 2. The reporter also explained this drug for RA is among only a few in a very lucrative field. Analysts predict tofacitinib would enjoy 3 billion dollar annual revenues.
It causes one to wonder about the about the financial ties or career promises to the eight panel members who voted yes.
The problems with tofacitinib
Concerned FDA scientists had seen evidence of cancer cells with malignant potential from the tests provided by Pfizer. Pneumonia occurred among some of the test subjects as well as other infectious diseases. Liver enzyme counts were high among others, indicating liver stress.
It's standard screening for drug human testing programs to eliminate test applicants with high liver enzyme counts. So those high counts occurred while they were taking the drug.
Since RA is an auto-immune disease with an overactive immune system attacking several different healthy joint areas at once,
Pfizer had the bright idea of suppressing the immune system with their latest creation. It's no wonder one can attract other diseases with this drug. It diminishes the immune system.
Tofacitinib is not an intelligent immune regulator, such as vitamin D3 and the herb Ashwaganda. Immune regulators adjust the immune system up or down as required. Tofacitinib simply suppresses the immune system like a blanket 24/7.
You may get relief from
arthritis only to endure other ailments, including cancer. That's good for business but bad for naive pill poppers.
Rheumatoid arthritis (RA) treatment alternatives
Big Pharma thrives on more sickness, real, invented, or created by pharmaceutical side effects. Taking their meds is absolute folly. But RA is more of a challenge than many other modern day ailments since its root cause is not fully understood.
Why it tends to afflict women more than men is not clear. One hypothesis involves
estrogen issues.Boosting
vitamin D3 blood levels to between 50 and 70 nanograms per milliliter is an obvious treatment. Studies have shown that women deficient in D3 are more likely to suffer from rheumatoid arthritis. Here's a report on one of the studies (
http://www.naturalnews.com/028690_Rheumatoid_arthritis_vitamin_D.html).
Glucosomine combined with pure omega-3 fatty acids is becoming a standard approach for alternative natural relief with potential healing possibilities (
http://www.naturalnews.com/027652_glucosamine_bones.html).
High quality unadulterated aloe Vera, consumed orally and applied topically has shown a good measure of success with rheumatoid arthritis.
Acupuncture, orthomolecular medicine and yoga are all helpful.
Choose a style of hatha yoga that's more gentle and relaxing than vigorous.An
organic vegetarian diet eliminating gluten has helped many suffering from RA. Mike Adams has arranged a list of foods that are helpful for RA (
http://www.healingfoodreference.com/rheumatoid_arthritis.html).
Sources for this article include:http://www.reuters.comhttp://www.huffingtonpost.comhttp://www.ehow.comhttp://www.empowher.com
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Now Available from 
